Asparagus Root Extract Shows Promise for Perimenopausal Hormone Balance
Standardized Asparagus racemosus extract significantly reduced hot flashes and improved hormonal balance in perimenopausal women.
Summary
A randomized controlled trial of 50 perimenopausal women found that a standardized Asparagus racemosus root extract (CL22205) significantly improved menopausal symptoms over 120 days. The supplement reduced hot flashes, menstrual discomfort, and hormonal imbalances while improving skin and hair quality. Participants taking 200mg daily showed decreased FSH and LH levels, increased anti-Müllerian hormone, and better overall quality of life scores compared to placebo, with no adverse effects reported.
Detailed Summary
Perimenopause brings challenging symptoms including hot flashes, hormonal fluctuations, and menstrual irregularities that significantly impact women's quality of life. Traditional Ayurvedic medicine has long used Asparagus racemosus (Shatavari) for female reproductive health, but rigorous clinical evidence has been limited.
Researchers conducted a randomized, double-blind, placebo-controlled trial with 50 perimenopausal women aged 40-50 experiencing mild to moderate climacteric symptoms. Participants received either 200mg daily of standardized A. racemosus root extract (CL22205) or placebo for 120 consecutive days.
The results were striking. Women taking the extract showed significant improvements in Menopausal Rating Scale scores and Hot Flash Weekly Weighted Scores compared to placebo. Hormonal markers improved dramatically: FSH decreased by 56.3%, LH by 34.3%, while anti-Müllerian hormone increased by 188.1%. Menstrual symptoms including dysmenorrhea were substantially reduced, and participants reported better skin and hair quality.
These findings suggest A. racemosus extract could offer a natural alternative for managing perimenopausal symptoms. The supplement appeared to help restore hormonal balance and reduce vasomotor symptoms without adverse effects. However, this was a relatively small, short-term study, and longer trials with larger populations are needed to confirm these promising results and establish optimal dosing protocols.
Key Findings
- 56.3% reduction in FSH and 34.3% reduction in LH levels after 120 days
- 188.1% increase in anti-Müllerian hormone levels
- Significant reduction in hot flashes and menstrual discomfort
- Improved skin and hair quality with no adverse events
- Better overall menopausal symptom scores versus placebo
Methodology
Randomized, double-blind, placebo-controlled trial with 50 perimenopausal women aged 40-50. Participants received 200mg daily of standardized A. racemosus extract or placebo for 120 days, with comprehensive hormonal and symptom assessments.
Study Limitations
Small sample size of only 50 participants and relatively short 120-day duration limit generalizability. Longer-term safety data and larger trials are needed to establish optimal dosing and confirm sustained benefits.
Enjoyed this summary?
Get the latest longevity research delivered to your inbox every week.